I think that slide 4 of the presentation helps a little.
It outlines the 4 reasons of why there was no revenue growth in 2018 and what they plan to do in 2019 to get back on track.
Slide 13 provides some emphasis that things are improving.
I think that the business will recover revenue and that it will continue to grow.
It is a great business with a good moat.
HT1
- Forums
- ASX - By Stock
- IRI
- Ann: Results Briefing FY2018
Ann: Results Briefing FY2018, page-5
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IRI (ASX) to my watchlist
(20min delay)
|
|||||
Last
59.5¢ |
Change
0.010(1.71%) |
Mkt cap ! $104.7M |
Open | High | Low | Value | Volume |
61.0¢ | 61.0¢ | 58.5¢ | $169.4K | 281.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 3055 | 59.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
59.5¢ | 212 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2575 | 2.440 |
2 | 897 | 2.430 |
2 | 7887 | 2.420 |
2 | 2724 | 2.410 |
2 | 8724 | 2.400 |
Price($) | Vol. | No. |
---|---|---|
2.450 | 5861 | 2 |
2.460 | 17285 | 6 |
2.470 | 724 | 1 |
2.480 | 22461 | 5 |
2.490 | 17590 | 5 |
Last trade - 15.16pm 25/11/2024 (20 minute delay) ? |
Featured News
IRI (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online